Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.
暂无分享,去创建一个
A. Zanetti | M. Chironna | M. Tosti | E. Spada | A. Mele | C. Zotti | M. Cuccia | R. Coppola | O. Zuccaro | E. Zamparo | A. Parlato | L. Romano | S. Paladini | R. Mangione | F. Marrone | F. S. Negrone
[1] P. van Damme,et al. Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory. , 2012, Vaccine.
[2] Min Zhang,et al. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. , 2011, Vaccine.
[3] J. Tvrdík,et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up , 2010, Infection.
[4] Chien-Jen Chen,et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students , 2010, Hepatology.
[5] A. Theamboonlers,et al. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. , 2010, Vaccine.
[6] Thomas W. Hennessy,et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. , 2009, The Journal of infectious diseases.
[7] P. De Wals,et al. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later. , 2009, Vaccine.
[8] A. Theamboonlers,et al. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. , 2009, The Journal of infectious diseases.
[9] M. Yuen,et al. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. , 2008, Vaccine.
[10] P. van Damme,et al. The global impact of vaccination against hepatitis B: a historical overview. , 2008, Vaccine.
[11] Ryan T Novak,et al. Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth: A 15-Year Follow-Up Study , 2008, The Pediatric infectious disease journal.
[12] K. Herck,et al. Benefits of Early Hepatitis B Immunization Programs for Newborns and Infants , 2008, The Pediatric infectious disease journal.
[13] Mei-Hwei Chang,et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. , 2008, The Journal of infectious diseases.
[14] P. Lopalco,et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Chung-Yi Li,et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. , 2007, Vaccine.
[16] A. Zanetti,et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. , 2007, Vaccine.
[17] P. Lopalco,et al. Erratum: Acute delta hepatitis in Italy: Incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign (Clinical Infectious Diseases (2007) 44 (e17-24)) , 2007 .
[18] P. Lopalco,et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] A. Zanetti,et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.
[20] B. McMahon,et al. Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy , 2005, Pediatrics.
[21] B. McMahon,et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. , 2005, Vaccine.
[22] P. De Wals,et al. Comparative Long Term Immunogenicity of Two Recombinant Hepatitis B Vaccines and the Effect of a Booster Dose Given After Five Years in a Low Endemicity Country , 2005, The Pediatric infectious disease journal.
[23] M. Yuen,et al. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] D. Kelly,et al. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. , 2004, The Journal of infectious diseases.
[25] H. Margolis,et al. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. , 2001, Vaccine.
[26] P. van Damme,et al. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. , 2000, Vaccine.
[27] B. McMahon,et al. Increases in levels of antibody to hepatitis B surface antigen in an immunized population. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] E. Tanzi,et al. Vaccination against hepatitis B: the Italian strategy. , 1993, Vaccine.
[29] N. Abrescia,et al. MASS VACCINATION AGAINST HEPATITIS B IN INFANTS IN ITALY , 1988, The Lancet.